Meningitis: three students infected in , a vaccination campaign launched

Meningitis: three students infected in , a vaccination campaign launched
Meningitis: three students infected in Grenoble, a vaccination campaign launched

Three students from have been infected with an invasive meningococcal infection in recent days.

They were all hospitalized between September 16 and 20, specifies the Regional Health Agency (ARS).

A vaccination campaign was organized.

Three cases of meningitis have been detected in Grenoble in recent days. They concern students victims of an invasive meningococcal infection (meningitis) diagnosed between September 16 and 20 and requiring their hospitalization, indicated the Auvergne-Rhône-Alpes Regional Health Agency (ARS). Their state of health “is now reassuring”, the latter specified this Monday, September 30, emphasizing that no new cases have been reported since September 20.

People who were in contact with the three infected students, namely their relatives but also their classmates, received preventive antibiotic treatment.

“Rapidly appearing red or purplish spots”

The regional health agency also indicated that a vaccination campaign will be launched in the coming days. “The students concerned will be informed directly as soon as the practical arrangements are finalized,” she warned.

  • Read also

    Meningitis: the number of cases of meningococci at an unprecedented level in for ten years

These three recent cases of meningitis are an opportunity for the ARS to recall the symptoms of this disease which can be fatal, namely fever, severe headache, vomiting, but also “rapidly appearing red or purplish spots”.

The infected person may also be affected by “disorders of consciousness, pale or even gray facial color, diarrhea, intolerance to light or noise, stiff neck, significant aches, significant drowsiness, eye paralysis or even convulsions “, details the agency which invites to contact “immediately” on the 15th in the event of the appearance of such symptoms.


A. LG

-

-

PREV The flu vaccination rate among those over 65 remains too low
NEXT Discover our 2024 Alzheimer research report